Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H16N2O3 |
Molecular Weight | 248.2777 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C(=O)NC(=O)NC(C)=O)C1=CC=CC=C1
InChI
InChIKey=GBPZSCQLDXUGNO-UHFFFAOYSA-N
InChI=1S/C13H16N2O3/c1-3-11(10-7-5-4-6-8-10)12(17)15-13(18)14-9(2)16/h4-8,11H,3H2,1-2H3,(H2,14,15,16,17,18)
Molecular Formula | C13H16N2O3 |
Molecular Weight | 248.2777 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: http://rad-ar.or.jp/siori/english/kekka.cgi?n=35325
Sources: http://rad-ar.or.jp/siori/english/kekka.cgi?n=35325
Acetylpheneturide (P-3981/Crampol) is used as an anticonvulsant in the treatment of epilepsy. It is usually used to treat convulsive attacks of epilepsy, psychomotor attacks and autonomic attacks. This medicine suppresses epileptic attacks by acting on the central nerves. The most commonly reported adverse reactions include generalized red rash.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: central nerves Sources: http://rad-ar.or.jp/siori/english/kekka.cgi?n=35325 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | CRAMPOL Powder Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://rad-ar.or.jp/siori/english/kekka.cgi?n=35325
for adults, start by taking the dose at 0.3 to 0.4 g, and for children, 0.1 to 0.2 g, three times a day after each meal
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:20:47 GMT 2023
by
admin
on
Fri Dec 15 17:20:47 GMT 2023
|
Record UNII |
G083008IJ0
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2107062
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | |||
|
DTXSID8048789
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | |||
|
100000077973
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | |||
|
1999
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | |||
|
G083008IJ0
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | |||
|
236-493-6
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | |||
|
m995
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | Merck Index | ||
|
13402-08-9
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | |||
|
SUB12725MIG
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY | |||
|
72
Created by
admin on Fri Dec 15 17:20:47 GMT 2023 , Edited by admin on Fri Dec 15 17:20:47 GMT 2023
|
PRIMARY |